This month, we’re featuring Staci Hepler, whose work spans teaching, research, and service.
Health Policy Statistics Section
Ghosh-Dastidar Honored with Outstanding Science Alumni Award
Past ASA President Bonnie Madhumita Ghosh-Dastidar was recognized for making significant professional contributions and demonstrating a strong commitment to mentorship.
My ASA Story: Bonnie Ghosh-Dastidar
Bonnie Ghosh-Dastidar’s journey from Penn State to ASA president highlights her dedication to real-world statistics, health policy, the ASA, and gender balance in the field.
Health Policy Statistics Section Seeks Award Nominations
Nominate a colleague for one of the Health Policy Statistics Section’s achievement awards.
Counting Down to JSM 2024
With the theme “Statistics and Data Science: Informing Policy and Countering Misinformation,” this conference anticipates more than 5,000 attendees and 600 sessions. Learn about the featured speakers and events.
COPSS Selects 2024 Award Honorees
The Committee of Presidents of Statistical Societies selected eight Emerging Leader Award winners as well as the winners of the Distinguished Achievement Award and Lectureship, Elizabeth L. Scott Award, and Presidents’ Award.
ICHPS 2023 Offers Opportunity for Professional Growth, Innovative Thinking
The International Conference on Health Policy Statistics was held January 9–11 in Scottsdale, Arizona, bringing together practitioners, methodologists, health service researchers, health economists, and policy analysts.
Meet the JSM 2022 Featured Speakers
Catch all of these featured speakers at JSM 2022 in Washington, DC.
My ASA Story: Kelly Zou, Researcher
Kelly H. Zou, PStat, is head of Medical Analytics and Real World Evidence at Viatris. Here, she tells us about her ASA journey.
NISS-Merck-HPSS Meet-Up Focuses on RWD
RWD and its applications in the pharmaceutical industry was the topic of the fourth virtual meet-up sponsored by the National Institute of Statistical Sciences and Merck and co-sponsored by the ASA’s Health Policy Statistics Section for the first time this year. Big data, real-world data, and observational data have become ubiquitous and essential components of the drug development and commercialization process.